
|Articles|February 1, 1998
The American Journal of Managed Care
- February 1998
- Volume 4
- Issue 2
Differential Effects of Inhaled Corticosteroids: Fluticasone Propionate Versus Triamcinolone Acetonide
Advertisement
Articles in this issue
almost 28 years ago
Physicians' Perceptions of Managed Carealmost 28 years ago
The Pharmacoeconomic Benefits of Cholesterol Reductionalmost 28 years ago
The Neonatologist as Primary Care Physicianalmost 28 years ago
Menopause and Controversies in Hormone Replacement Therapyalmost 28 years ago
An Update on the Treatment of Premenstrual Syndromealmost 28 years ago
Physicians' Perceptions of Managed CareNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
2
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
3
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
4
The Changing Treatment Landscape of IPF and PPF: Toby Maher, MD, PhD
5














































